NCT06776354Completed
AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
Application of Artificial Intelligence in Hypertension Pharmacotherapy Education: A Comparative Study of the GPT System and Traditional Teaching Methods
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
Educational Trial: GPT-Based Training vs. Traditional Teaching for Hypertension Management The goal of this educational trial is to determine whether a Generative Pre-trained Transformer (GPT)-based training system is more effective than traditional teaching methods in helping medical students master hypertension management plans. It will also evaluate the educational effectiveness and engagement of the GPT-based system. The main questions it aims to answer are: Does the GPT-based training improve the ability of students to develop effective hypertension management plans compared to traditional methods? How do students perceive the use of the GPT system in their learning process? Researchers will compare the GPT-based training system to traditional teaching methods to see if the innovative AI approach enhances learning outcomes in medical education. Participants will: Engage with either the GPT-based system or traditional teaching materials. Visit the educational facility periodically for assessments and feedback sessions. Keep a diary of their learning experiences, noting any difficulties or advantages they observe in the training method they are assigned.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 27 Dec 2024
- Start date
- 20 Oct 2024
- Primary completion date
- 12 Jul 2025
- Lead sponsor
- zhen wang
- Diseases
- High blood pressure
- NCT number
- NCT06776354
What you commit to
- Study type: Interventional
- Participants enrolled: 52
- From 20 Oct 2024 to the primary completion date, 12 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Graduate students or trained interns who have received specialized training in hypertension medication treatment.
Other
- Students unable to complete the full course of study (e.g., rotations shorter than four weeks or potential mid-course withdrawal).
- Unable to consistently participate in educational interventions (e.g., conflicts with study schedule).
- Have severe physical or mental health issues that may affect the learning process.
- Have language comprehension barriers or cognitive impairments, making it difficult to complete learning tasks.
Who the study is looking for
- Graduate or regulatory trainee, currently rotating in cardiology and willing to participate in research.
- Age between 18-30 years old, gender not limited.
- No specialized training experience in hypertension diagnosis and treatment, only possessing basic medical theoretical knowledge.
- Able to accept a 4-week teaching intervention (2 hours of study per week).
- Sign the informed consent form and be aware of the research purpose and process.
Age in the registry: 18 years to 30 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 678 Furong Road, Economic Development Zone, Hefei City, Anhui Province, China Coordinator of this site? Confirm its status | Hefei | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.